Safety and Efficacy of Intrathecal Rituximab in Children with Non-Hodgkin Lymphoma: A Retrospective Study

Xiong X.; Li Y.; Peng X.; Chuchu F.; Pingping W.; Wenjun W.

首页> 外文期刊>Pediatric blood & cancer >Safety and Efficacy of Intrathecal Rituximab in Children with Non-Hodgkin Lymphoma: A Retrospective Study

【24h】

Safety and Efficacy of Intrathecal Rituximab in Children with Non-Hodgkin Lymphoma: A Retrospective Study

机译：非霍奇金淋巴瘤儿童鞘内的安全性和有效性：回顾性研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2019年第s4期|共1页
作者
Xiong X.; Li Y.; Peng X.; Chuchu F.; Pingping W.; Wenjun W.;
展开▼
作者单位

Sun Yat Sen Univ Sun Yat Sen Mem Hosp Pediat Hematol Oncol Guangzhou Guangdong Peoples R China;

Sun Yat Sen Univ Sun Yat Sen Mem Hosp Pediat Hematol Oncol Guangzhou Guangdong Peoples R China;

Sun Yat Sen Univ Sun Yat Sen Mem Hosp Pediat Hematol Oncol Guangzhou Guangdong Peoples R China;

Sun Yat Sen Univ Sun Yat Sen Mem Hosp Pediat Hematol Oncol Guangzhou Guangdong Peoples R China;

Sun Yat Sen Univ Sun Yat Sen Mem Hosp Pediat Hematol Oncol Guangzhou Guangdong Peoples R China;

Sun Yat Sen Univ Sun Yat Sen Mem Hosp Pediat Hematol Oncol Guangzhou Guangdong Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and Efficacy of Intrathecal Rituximab in Children with Non-Hodgkin Lymphoma: A Retrospective Study [J] . Xiong X., Li Y., Peng X., Pediatric blood & cancer . 2019,第S4期

机译：非霍奇金淋巴瘤儿童鞘内的安全性和有效性：回顾性研究
2. A randomized, multiple-dose, multicenter, comparative parallel study to evaluate the safety and efficacy of intravenous infusion of rituximab (Hetero) and reference medicinal product (Rituximab, Roche) in Indian patients of non-hodgkin's lymphoma (HERILY) [J] . Suresh Advani, Ghanashyam Biswas, Shubhadeep Sinha, Indian Journal of Medical and Paediatric Oncology . 2018,第3期

机译：一项随机，多剂量，多中心，比较平行研究，以评估印度非霍奇金淋巴瘤（HERILY）患者静脉注射利妥昔单抗（Hetero）和参考药物（Rituximab，Roche）的安全性和有效性
3. Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin's Lymphoma: A Systematic Review and Meta-analysis [J] . Lee Soohyun, Lee Heeyoung, Kim EunYoung BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy . 2019,第5期

机译：生物仿生生物蛋白生物酸碱和发芽中的对比疗效和安全性 - 类风湿性关节炎和非霍奇金淋巴瘤中的疗效和荟萃分析
4. Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma [C] . Bohua Li, Hao Wang, Yajun Guo, International conference of molecular simulations and applied informatics technologies . 2012

机译：具有抗利妥昔单抗的B细胞淋巴瘤的有效抗肿瘤活性的利妥昔单抗变体的表征
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Efficacy and safety of biosimilar rituximab (ZytuxTM) in newly diagnosed patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia [O] . Alaa Fadhil Alwan, Manal Ali Abdulsahib, Duaa Dhahir Abbas, 2020

机译：生物仿生毒液（ZyTuxtm）在新诊断患有非霍奇金淋巴瘤和慢性淋巴细胞白血病患者中的疗效和安全性
7. Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study [O] . Ceppi, Francesco, Weitzman, Sheila, Woessmann, Wilhelm, 2016

机译：鞘内注射利妥昔单抗治疗儿童B细胞淋巴样CD20 +恶性肿瘤的安全性和有效性：一项国际回顾性研究

Safety and Efficacy of Intrathecal Rituximab in Children with Non-Hodgkin Lymphoma: A Retrospective Study

著录项

相似文献

相关主题

期刊订阅